| abstract |
The invention discloses compounds of formula I n n n n n n n n n n n n wherein Y is a group of formula A, B, C, D, or E: n n n n n n n n n n n n n n n n and W, Q, n, R1, R2, R3, U1-U5, J and K have the meanings given in the description. n n n n n The compounds of formula I are TRPV1 antagonists and are useful as active ingredients of pharmaceutical compositions for the treatment of pain and other conditions ameliorated by the inhibition of the vanilloid receptor TRPV1. |